OptimizeRx (NASDAQ:OPRX) Upgraded by Zacks Investment Research to Hold

OptimizeRx} stock has undergone multiple analysts rating changes in the recent past.  OptimizeRx Upgraded by Zacks Investment Research on 10/28/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More OptimizeRx (NASDAQ:OPRX) Upgraded by Zacks Investment Research to Hold

OptimizeRx (NASDAQ:OPRX) Downgraded by Zacks Investment Research to Sell

OptimizeRx} stock has undergone multiple analysts rating changes in the recent past.  OptimizeRx Downgraded by Zacks Investment Research on 10/21/2021. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Hold.

View More OptimizeRx (NASDAQ:OPRX) Downgraded by Zacks Investment Research to Sell